BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 6079865)

  • 1. Tumor-specific antigen(s) in a spontaneous mammary carcinoma of C3H mice. II. Active immunization of mammary-tumor-agent-free mice.
    Suit HD; Silobrcic V
    J Natl Cancer Inst; 1967 Dec; 39(6):1121-8. PubMed ID: 6079865
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor-specific antigen(s) in a spontaneous mammary carcinoma of C3H mice. I. Quantitative cell transplants into mammary-tumor-agent-positive and -free mice.
    Silobrcic V; Suit HD
    J Natl Cancer Inst; 1967 Dec; 39(6):1113-9. PubMed ID: 6079864
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhanced immune reactivity to hepatoma 22a cells in MTV-infected compared with MTV-free C3H mice.
    Lavrovsky VA; Viksler VK
    Immunology; 1981 Dec; 44(4):671-6. PubMed ID: 6274791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in lymphoreticular tissues during growth of a murine adenocarcinoma. 3. Plaque-forming cell response in lymph nodes and spleen.
    Rowland GF; Edwards AJ; Hurd CM; Sumner MR
    J Natl Cancer Inst; 1971 Aug; 47(2):321-7. PubMed ID: 4934422
    [No Abstract]   [Full Text] [Related]  

  • 5. Protective serum effects in tumor immunity.
    Vaage J
    Isr J Med Sci; 1976; 12(4-5):334-43. PubMed ID: 939693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro studies on tumor-specific immunity by using C3H mammary cancer-A cells. 3. Specificity of aggregation of sensitized lymph-node cells on target cells.
    Satoh K
    Acta Med Okayama (1952); 1967 Apr; 21(2):67-78. PubMed ID: 4229455
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunologic interactions between isologous or F1 hybrid hosts and spontaneous mammary tumors in CBA-Bln mice.
    Müller M
    Cancer Res; 1967 Dec; 27(12):2272-9. PubMed ID: 4866761
    [No Abstract]   [Full Text] [Related]  

  • 9. Acquired immunological tolerance and carcinogenesis by the mammary tumor virus. II. Immune responses influencing growth of spontaneous mammary adenocarcinomas.
    Morton DL; Goldman L; Wood DA
    J Natl Cancer Inst; 1969 Feb; 42(2):321-9. PubMed ID: 4303884
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the tumor-host relationship. II. Serum resistant factor(s) produced by tumor transplantation.
    Tanino T
    Jpn J Exp Med; 1968 Oct; 38(5):383-92. PubMed ID: 5305973
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlation between tumor-specific systemic and in situ immunity as manifested by the delayed hypersensitivity response.
    Radov LA; Haskill JS; Korn JH; Fett JW
    J Natl Cancer Inst; 1979 Jan; 62(1):103-8. PubMed ID: 281564
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of tumour-associated transplantation antigen of BO-IV carcinoma on somatic cells of tumour-free syngeneic mice. II. Search for a common antigen in some organs and spontaneous mammary carcinomas.
    Rejthar A; Wotke J
    Folia Biol (Krakow); 1973; 21(1):52-7. PubMed ID: 4693119
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor control by irradiation: A C3H-He mouse mammary carcinoma in mammary-tumor-agent-positive and mammary-tumor-agent-free mice.
    Suit H; Kastelan A
    J Natl Cancer Inst; 1968 May; 40(5):945-50. PubMed ID: 5648138
    [No Abstract]   [Full Text] [Related]  

  • 14. Demonstration of tumor-specific immunity against antigens unrelated to the mammary tumor virus in spontaneous mammary adenocarcinomas.
    Morton DL; Miller GF; Wood DA
    J Natl Cancer Inst; 1969 Feb; 42(2):289-301. PubMed ID: 4303881
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune responsiveness to a murine mammary carcinoma modified to express B7-1, interleukin-12, or GM-CSF.
    Aruga E; Aruga A; Arca MJ; Lee WM; Yang NS; Smith JW; Chang AE
    Cancer Gene Ther; 1997; 4(3):157-66. PubMed ID: 9171934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L; Hunter N; Mason K; Withers HR
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor specificity, serum inhibition, and influence of regional lymph nodes on cytotoxic macrophages from cultured bone marrow.
    Fisher B; Hanlon JT; Linta J; Saffer E
    Cancer Res; 1977 Oct; 37(10):3628-33. PubMed ID: 908011
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppression of autochthonous grafts of spontaneous mammary tumor by induced allogeneic graft rejection mechanism.
    Tokuzen R; Nakahara W
    Cancer Res; 1973 Apr; 33(4):645-7. PubMed ID: 4696465
    [No Abstract]   [Full Text] [Related]  

  • 19. [Induction of specific resistance in Swiss mice using x-irradiated cells of the ATPC+ ascitic tumor].
    Marconi P; Fimiani E; Bistoni F; Latini A
    Boll Soc Ital Biol Sper; 1973 May; 49(10):529-33. PubMed ID: 4132961
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of serial transplantation on the immunological-clinical correlates of BALB/cfC3H mouse mammary tumors.
    Hager JC; Miller FR; Heppner GH
    Cancer Res; 1978 Aug; 38(8):2492-500. PubMed ID: 667845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.